Meeting
2024 ASCO Genitourinary Cancers Symposium
Rethinking the definition of stage IV disease in adrenocortical carcinoma: Assessing the impact of clinical lymph node positive disease.
Authors
Helen Gao
Rutgers-RWJ Medical School, Piscataway, NJ
Helen Gao , Benjamin Lichtbroun , Kevin J. Chua , Arnav Srivastava , John Pfail , David Golombos , Thomas L. Jang , Saum Ghodoussipour
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer
Sub Track
Other
Citation
J Clin Oncol 42, 2024 (suppl 4; abstr 5)
DOI
10.1200/JCO.2024.42.4_suppl.5
Abstract #
5
Poster Bd #
E4
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Quality Care Symposium
Healthcare contact days for patients with stage IV non-small cell lung cancer (NSCLC) in Ontario: A population-based study.
First Author: Arjun Gupta
Poster
2023 ASCO Genitourinary Cancers Symposium
Impact of number of positive lymph nodes on prognostic stratification in renal cell carcinoma: Analysis of the National Cancer Database.
First Author: Luke Wang
Poster
2023 ASCO Genitourinary Cancers Symposium
Adrenocortical carcinoma: Report of data from 66 patients with a rare disease at a cancer center.
First Author: Rafael Haikal dos Santos Abduch
Poster
2021 ASCO Quality Care Symposium
Overall survival benefits of advances in NSCLC systemic treatments: Younger versus older adults.
First Author: Bonnie Leung